(Press-News.org) An ‘AI scientist’, working in collaboration with human scientists, has found that combinations of cheap and safe drugs – used to treat conditions such as high cholesterol and alcohol dependence – could also be effective at treating cancer, a promising new approach to drug discovery.
The research team, led by the University of Cambridge, used the GPT-4 large language model (LLM) to identify hidden patterns buried in the mountains of scientific literature to identify potential new cancer drugs.
To test their approach, the researchers prompted GPT-4 to identify potential new drug combinations that could have a significant impact on a breast cancer cell line commonly used in medical research. They instructed it to avoid standard cancer drugs, identify drugs that would attack cancer cells while not harming healthy cells, and prioritise drugs that were affordable and approved by regulators.
The drug combinations suggested by GPT-4 were then tested by human scientists, both in combination and individually, to measure their effectiveness against breast cancer cells.
In the first lab-based test, three of the 12 drug combinations suggested by GPT-4 worked better than current breast cancer drugs. The LLM then learned from these tests and suggested a further four combinations, three of which also showed promising results.
The results, reported in the Journal of the Royal Society Interface, represent the first instance of a closed-loop system where experimental results guided an LLM, and LLM outputs – interpreted by human scientists – guided further experiments. The researchers say that tools such as LLMs are not replacement for scientists, but could instead be supervised AI researchers, with the ability to originate, adapt and accelerate discovery in areas like cancer research.
Often, LLMs such as GPT-4 return results that aren’t true, known as hallucinations. But in scientific research, hallucinations can sometimes be a benefit, if they lead to new ideas that are worth testing.
“Supervised LLMs offer a scalable, imaginative layer of scientific exploration, and can help us as human scientists explore new paths that we hadn’t thought of before,” said Professor Ross King from Cambridge’s Department of Chemical Engineering and Biotechnology, who led the research. “This can be useful in areas such as drug discovery, where there are many thousands of compounds to search through.”
Based on the prompts provided by the human scientists, GPT-4 selected drugs based on the interplay between biological reasoning and hidden patterns in the scientific literature.
“This is not automation replacing scientists, but a new kind of collaboration,” said co-author Dr Hector Zenil from King’s College London. “Guided by expert prompts and experimental feedback, the AI functioned like a tireless research partner—rapidly navigating an immense hypothesis space and proposing ideas that would take humans alone far longer to reach.”
The hallucinations – normally viewed as flaws – became a feature, generating unconventional combinations worth testing and validating in the lab. The human scientists inspected the mechanistic reasons the LLM found to suggest these combinations in the first place, feeding the system back and forth in multiple iterations.
By exploring subtle synergies and overlooked pathways, GPT-4 helped identify six promising drug pairs, all tested through lab experiments. Among the combinations, simvastatin (commonly used to lower cholesterol) and disulfiram (used in alcohol dependence) stood out against breast cancer cells. Some of these combinations show potential for further research in therapeutic repurposing.
These drugs, while not traditionally associated with cancer care, could be potential cancer treatments, although they would first have to go through extensive clinical trials.
“This study demonstrates how AI can be woven directly into the iterative loop of scientific discovery, enabling adaptive, data-informed hypothesis generation and validation in real time,” said Zenil.
“The capacity of supervised LLMs to propose hypotheses across disciplines, incorporate prior results, and collaborate across iterations marks a new frontier in scientific research,” said King. “An AI scientist is no longer a metaphor without experimental validation: it can now be a collaborator in the scientific process.”
The research was supported in part by the Alice Wallenberg Foundation and the UK Engineering and Physical Sciences Research Council (EPSRC).
END
‘AI scientist’ suggests combinations of widely available non-cancer drugs can kill cancer cells
2025-06-04
ELSE PRESS RELEASES FROM THIS DATE:
Phage therapy at a turning point: Global experts converge in Berlin to shape the future of antimicrobial medicine
2025-06-03
As antibiotic resistance reaches critical levels worldwide, the 8th World Congress on Targeting Phage Therapy (June 10–11, 2025) returns to Berlin, bringing together over 75 international speakers and contributors from 27 countries. The congress offers the most comprehensive scientific and clinical update on phage therapy—a once-overlooked solution now at the forefront of next-generation medicine.
Phage Therapy 2025 covers the full translational pipeline: from phage–bacteria interactions and biofilm disruption to regulatory frameworks, GMP manufacturing, and ...
Low calorie diets linked to heightened risk of depressive symptoms
2025-06-03
Following a low calorie diet is linked to a heightened risk of depressive symptoms, finds research published in the open access journal, BMJ Nutrition Prevention & Health.
Men and those who are overweight may be especially vulnerable to the effects of restrictive eating, the findings suggest.
A ‘healthy’ diet rich in minimally processed foods, fresh fruits and vegetables, whole grains, nuts, seeds, lean proteins and fish, is generally associated with a lower risk of depression, while an ‘unhealthy’ diet, dominated by ultra-processed foods, refined carbs, saturated fats, processed ...
Bronchiolitis, monoclonal antibody halves hospitalizations of children younger than six months old
2025-06-03
A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug has been approved at the European level to protect infants in their first season of exposure to the virus) to infants can halve hospitalisations for bronchiolitis. It is the result of a study involving the Università Cattolica del Sacro Cuore, Rome campus - Fondazione Policlinico Universitario Agostino Gemelli IRCCS, co-ordinated by Universitat Politècnica de Catalunya (UPC), Catalonia, Children's Emergency Department, Leicester Royal Infirmary and University of Edinburgh, ...
Mum’s obesity linked to child’s heightened hospital admission risk for infection
2025-06-03
Children born to mothers who are very obese with a BMI of 35 or higher are at heightened risk of being admitted to hospital for an infection, finds a long term study published in the open access journal BMJ Medicine.
The findings highlight the importance of maintaining a healthy body weight before and after the pregnancy, say the researchers.
On current trends, the global prevalence of maternal obesity is projected to reach nearly 1 in 4 (23%) by 2030, point out the researchers. This is of particular concern, given that obesity is characterised by a state of chronic inflammation, which increases the risk of a disordered immune ...
Millions of new solar system objects to be found and ‘filmed in technicolor’ – studies predict
2025-06-03
A group of astronomers from across the globe, including a team from the University of Washington and led by Queen’s University Belfast, have revealed new research showing that millions of new solar system objects will be detected by a brand-new facility, which is expected to come online later this year.
The NSF–DOE Vera C. Rubin Observatory is set to revolutionize our knowledge of the solar system’s “small bodies” — asteroids, comets and other minor planets.
The Rubin Observatory, ...
Pitt study has upended decades-old assumptions about brain plasticity
2025-06-03
A new study from Pitt researchers challenges a decades-old assumption in neuroscience by showing that the brain uses distinct transmission sites — not a shared site — to achieve different types of plasticity. The findings, published in Science Advances, offer a deeper understanding of how the brain balances stability with flexibility, a process essential for learning, memory and mental health.
Neurons communicate through a process called synaptic transmission, where one neuron releases chemical messengers called neurotransmitters ...
Hertz Foundation partners with Analog Devices to empower future leaders in analog, digital and software technology solutions
2025-06-03
The Hertz Foundation, a nonprofit dedicated to empowering the nation’s most promising innovators, and Analog Devices, Inc. (ADI), a global semiconductor leader, have announced a new partnership to drive the next generation of scientific leadership in analog, digital, and software technology solutions.
Through the Hertz Fellowship – the nation’s most prestigious doctoral fellowship – and its influential network of 1,300 Hertz Fellows, the Hertz Foundation has been at the forefront of advancing science and technology for more than 60 years. Hertz Fellows are responsible for some of the most significant progress of the past century, from the recent launch of the ...
Would you hand over your health data if it meant better care?
2025-06-03
Despite growing concerns about data privacy, new research from the University of South Australia shows that most people are happy to hand over their health information if it could help improve their care.
In a new global study, UniSA researchers found that 94% of people who use wearable activity trackers – such as Fitbits, Garmins, as well as Samsung or Apple Watches – are open to sharing data with their healthcare providers.
Of these respondents, 47% of people had already discussed their data with their healthcare provider, ...
Study examines how well wearable tech tracks fitness metrics
2025-06-03
OXFORD, Miss. – Many Americans rely on their Apple Watches or similar devices each day to count their steps, track workouts, and measure how many calories they burn. But are those wearable devices accurate?
University of Mississippi professor Minsoo Kang and doctoral student Ju-Pil Choe are working to answer that question.
Kang, a professor of sport analytics, and Choe reviewed 56 studies that compared the Apple Watch to trusted reference tools in measuring energy burned, heart rate and step counts.
Data ...
Dr. Nikolaos Koundouros wins 2025 Tri-Institutional Breakout Award
2025-06-03
Dr. Nikolaos Koundouros, a postdoctoral associate in the Department of Pharmacology at Weill Cornell Medicine, has been awarded a 2025 Tri-Institutional Breakout Award for Junior Investigators.
Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and The Rockefeller University present the awards to up to six exceptional investigators each year—at least one from each institution—who are recognized for their notable research achievements, impactful findings and high potential for success as independent investigators. ...